Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001179110-19-004209

Options or other derivatives

  • Sr. VP Research acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Masuda Esteban · Sr. VP Research

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-20 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +62,500 $4.49 2028-01-24 62,500 62,500 D
Loading xslF345X03/edgar.xml…